Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclometasone HFA spacer-device crossover safety study in children with mild asthma
2007-003412-59Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate in asthma (4 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Lower leg growth rate. Started Aug 2007; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-003412-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003412-59.